期刊文献+

高尔基蛋白73、甲胎蛋白异质体3、甲胎蛋白和α-L-岩藻糖苷酶在肝脏疾病中的诊断价值 被引量:10

Diagnostic values of GP73,AFP- L3,AFP,and AFU for liver diseases
下载PDF
导出
摘要 目的比较高尔基蛋白73(GP73)、甲胎蛋白异质体3(AFP-L3)、甲胎蛋白(AFP)和α-L-岩藻糖苷酶(AFU)在不同肝脏疾病患者中的意义及其单项或联合检测诊断肝癌的价值。方法对2013年1-12月收治的272例肝癌患者、203例肝硬化患者、248例慢性肝炎患者及210例健康体检者血清中的GP73、AFP-L3、AFP和AFU水平进行检测。非正态分布的数据多组间比较采用Kruskal-Wallis H检验,组间两两比较采用Mann-Whitney U检验,率的比较用卡方检验。ROC曲线绘制分别以健康人组和非肝癌组(健康体检、慢性肝炎、肝硬化)为对照。联合指标先进行Logistic拟合后再做ROC曲线。结果 GP73水平肝硬化组[177.0(116.0,247.0)ng/ml]较肝癌组[141.0(83.3,218.8)ng/ml])和慢性肝炎组[151.0(83.0,235.3)ng/ml]高(U=22 116.5、21 052.0,P均<0.05);AFP-L3和AFP在肝癌组中的水平[11.3(4.3,21.2)%,78.4(7.1,2455.8)ng/ml]明显高于肝硬化组[6.0(4.0,8.0)%,10.0(3.8,49.5)ng/ml]和慢性肝炎组[7.0(5.0,9.0)%,18.8(4.4,79.6)ng/ml](P均<0.05)。以健康人血清样本为对照绘制的诊断肝癌的ROC曲线,GP73、AFP-L3、AFP和AFU的ROC曲线下面积(AUC)分别为0.827、0.817、0.901和0.680。由此可知在鉴别健康人和肝癌患者方面,前3者比AFU有较高的准确性。以非肝癌患者血清样本为对照绘制的诊断肝癌的ROC曲线,4个指标对应的AUC分别为0.573、0.734、0.753和0.552,可见AFP-L3和AFP对于诊断肝癌有一定的准确性,其敏感性和特异性达到最大时的cut off值依次为8.55%(56.6%,84.9%),49.88 ng/ml(57.7%,80.9%)。结论 GP73的上升与肝损伤及长期纤维化有关,其在诊断肝脏疾病中有较好的敏感性,AFP-L3和AFP在诊断肝癌方面特异性较好,AFP-L3和AFP两者联合应用可提高肝癌的诊断敏感性至62.1%。 Objective To compare the levels of Golgi glycoprotein 73 (GP73 ),alpha-fetoprotein heterogeneity 3 (AFP-L3 ),alpha-fetoprotein (AFP),and α-L-fucosidase (AFU)between patients with different liver diseases and the diagnostic value of any or a combi-nation of these makers for liver cancer.Methods The 272 patients with liver cancer,203 patients with liver cirrhosis,and 248 patients with chronic hepatitis admitted to our hospital from January to December,2013,as well as 210 healthy individuals,were included in the study.Serum levels of GP73,AFP-L3,AFP,and AFU were determined.Comparison of non -normally distributed data was made by Kruskal-Wallis H test,and multiple comparisons were made by Mann-Whitney U test.Comparison of rates was made by chi-square test. P〈0.05 was considered significantly different.Receiver operating characteristic (ROC)curves were drawn with healthy individuals and pa-tients with chronic hepatitis or liver cirrhosis as controls,and Logistic fitting and ROC analysis were used to evaluate the diagnostic values of these markers.Results The GP73 level of liver cirrhosis group (177.0 (116.0,247.0)ng/ml)was significantly higher than those of liver cancer group (141.0 (83.3,218.8)ng/ml)and chronic hepatitis group (151.0 (83.0,235.3)ng/ml)(U=22 116.5 and 21 052.0,P〈0.05 for both).The AFP-L3 and AFP levels of liver cancer group (11.3 (4.3,21.2)%and 78.4 (7.1,2455.8)ng/ml)were significantly higher than those of liver cirrhosis group (6.0 (4.0,8.0)%and 10.0 (3.8,49.5)ng/ml)and chronic hepatitis group (7.0 (5.0,9.0)%and 18.8 (4.4,79.6)ng/ml)(U=16009.0/16083.5 and 22456.5/22346.5,P〈0.05 for all).According to the ROC curves drawn u-sing healthy individuals as a control,the areas under the ROC curve (AUCs)for GP73,AFP-L3,AFP,and AFU were 0.827,0.817, 0.901,and 0.680,respectively;GP73,AFP-L3,and AFP had a higher diagnostic accuracy for liver cancer than AFU.According to the ROC curves drawn using non-liver cancer p
出处 《临床肝胆病杂志》 CAS 2014年第8期785-789,共5页 Journal of Clinical Hepatology
关键词 肝疾病 高尔基蛋白73 甲胎蛋白异质体 甲胎蛋白类 Α-L-岩藻糖苷酶 liver diseases golgi protein 73 ( GP73 ) alpha - fetoproteins L3 alpha - fetoproteins alpha - L - fucosidase
  • 相关文献

参考文献13

  • 1中华医学会传染病与寄生虫病学分会、肝病学分会病毒性肝炎防治方案[J].传染病信息,2001,19(1):56-62. 被引量:1
  • 2KLADNEY RD, BULLA GA, GUO L, et al. GP73, a novel Golgi- localized protein upregulated by viral infection [ J ]. Gene, 2000, 249(1 ) :53 -65. 被引量:1
  • 3SCHWEGLER EE, CAZARES L, STEEL LF, et al. SELDI - TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma [J]. Hepatol- ogy, 2005, 41 (3) : 634 -642. 被引量:1
  • 4孔祥亘,韩绍磊,郑昭敏,杜文军,陈士俊.高尔基体蛋白73联合甲胎蛋白异质体在原发性肝癌诊断中的价值[J].山东大学学报(医学版),2011,49(4):110-114. 被引量:29
  • 5毛一雷,杨华瑜,徐海峰,桑新亭,卢欣,杨志英,张锦春,钟守先,黄洁夫,张宏冰.新的肝癌血清标记物GP73在肝癌诊断中的初步研究[J].中华医学杂志,2008,88(14):948-951. 被引量:132
  • 6IFTIKHAR R, KLADNEY RD, HAVLIOGLU N, et al. Disease- and cell -specific expression of GP73 in human liver disease [J]. Am J Gastroenterol, 2004, 99(6) : 1087 -1095. 被引量:1
  • 7TIAN L, WANG Y, XU D, et at. Serological AFP/Golgi pro- tein 73 could be a new diagnostic parameter of hepatic disea- ses[J]. Int J Cancer, 2011, 129(8) : 1923 -1931. 被引量:1
  • 8LIU X, WAN X, LI Z, et al. Golgi protein 73 ( GP73), a use- ful serum marker in liver diseases[J]. Clin Chem Lab Med, 2011, 49(8) ; 1311 -1316. 被引量:1
  • 9CHOI JY, JUNG S W, KIM HY, et al. Diagnostic value of AFP - L3 and PIVKA- II in hepatocellular carcinoma according to total -AFP[J]. World J Gastroenterol, 2013, 19(3) : 339. 被引量:1
  • 10许文芳,费迎明,周建康,沈华江,陈雪芳,吕秋琼,丁予昀.血清GP73、AFP和AFP-L3联合检测在原发性肝癌诊断中的价值[J].中华实验和临床病毒学杂志,2011,25(4):286-288. 被引量:41

二级参考文献48

共引文献241

同被引文献104

  • 1葛建忠,励钢,皇甫金变,张勇威,赵小明,戈朝晖,王自立.创伤患者血液流变学变化的临床研究[J].现代中西医结合杂志,2007,16(7):914-915. 被引量:3
  • 2Wei Wu, Deng-Fu Yao, Yong-Mei Yuan, Ji-Wei Fan, Xiu-Feng Lu, Xiao-Hua Li, Li-Wei Qiu, Lei Zong and Xin-Hua Wu Research Center of Clinical Molecular Biology, Affiliated Hospital of Nantong University, Nantong 226001, China.Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):538-544. 被引量:26
  • 3赵晓东,刘波,姚咏明,张连阳,梁华平.严重创伤患者早期胰岛素强化治疗对外周血IFN-γ和IL-18水平的影响[J].中国急救医学,2007,27(1):1-3. 被引量:6
  • 4Ma L,Ji L,Yu Y,et al.Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma[J].Discov Med,2015,19(102):7-14. 被引量:1
  • 5Villanueva A,Hoshida Y,Battiston C,et al.Combining clinical,pathology,and gene expression data to predict recurrence of hepatocellular carcinoma[J].Gastroenterology,2011,140(5):1501-1512. 被引量:1
  • 6Hayashi M,Shimizu T,Hirokawa F,et a1.Clinicopathological risk factors for recurrence within one year after initial hepatectomy for hepatocellular carcinoma[J].Am Surg,2011,77(5):572-578. 被引量:1
  • 7Zhang X F,Lai E C,Kang X Y,et al.Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection[J].Ann Surg Oncol,2011,18(8):2218-2223. 被引量:1
  • 8Rubin J,Ayoub N,Kaldas F,et al.Management of recurrent hepatocellular carcinoma in liver transplant recipients:a systematic review[J].Exp Clin Transplant,2012,10(6):531-543. 被引量:1
  • 9Yao S,Zhang J,Chen H,et al.Diagnostic value of immunohistochemical staining of GP73,GPC3,DCP,CD34,CD31,and reticu Iinstaining in hepatocellular carcinoma[J].JHistochem Cytochem,2013,61(9):639-648. 被引量:1
  • 10Subwongcharoen S,Leelawat K,Treepongkaruna S A,et al.Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses[J].J Med Assoc Thai,2011,94(Suppl 2):46-51. 被引量:1

引证文献10

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部